Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Evoke Pharma, Inc.

Evoke Pharma, Inc. (EVOK) Stock Overview

Explore Evoke Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EVOK●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$11.00
$0.00(0.00%)
U.S. Market is Open · 13:56

Evoke Pharma, Inc. (EVOK)

Meyka AI Score

Z

Key Financials

Market Cap18.9M
P/E Ratio-6.96
EPS (TTM)$-1.38
ROE-0.89%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

EVOK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Evoke Pharma, Inc. (NASDAQ: EVOK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Evoke Pharma, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EVOK on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Evoke Pharma, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.96 and a market capitalization of 18.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EVOK on the NASDAQ.

Price Performance (NASDAQ: EVOK)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
143.36%
6-Month Change
125.41%
Year-to-Date (YTD) Change
N/A
1-Year Change
146.64%
3-Year Change
-71.08%
5-Year Change
-97.42%
All-Time (Max) Change
-99.35%

Contact Information

https://www.evokepharma.com
858 345 1494
420 Stevens Avenue, Solana Beach, CA, 92075

Company Facts

30 Employees
IPO DateSep 25, 2013
CountryUS

Frequently Asked Questions